(NASDAQ: PODD) Insulet's forecast annual revenue growth rate of 16.46% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.25%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.24%.
Insulet's revenue in 2025 is $2,198,900,000.On average, 9 Wall Street analysts forecast PODD's revenue for 2025 to be $177,856,290,900, with the lowest PODD revenue forecast at $176,725,506,638, and the highest PODD revenue forecast at $179,737,553,342. On average, 9 Wall Street analysts forecast PODD's revenue for 2026 to be $209,854,783,140, with the lowest PODD revenue forecast at $204,960,629,494, and the highest PODD revenue forecast at $212,736,354,737.
In 2027, PODD is forecast to generate $245,393,274,755 in revenue, with the lowest revenue forecast at $238,407,719,149 and the highest revenue forecast at $250,640,288,265.